14159, L.P., Director, 10% Owner at SYNAGEVA BIOPHARMA CORP (GEVA), bought 1,050,000 shares at $56.63 ($59.5M) on 2013-09-25, disclosed to the SEC on 2013-09-27.
Open-market purchase of $59.5M GEVA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.63 | 25,663 | $1.5M | 2.4% |
| 2 | $56.63 | 1,024,337 | $58.0M | 97.6% |
| Total | $56.63 avg | 1,050,000 | $59.5M | 100% |
| Filing → |
| GHDX | SELL | 2019-01-14 | $2.8M | — | Filing → |
| ACAD | BUY | 2018-12-04 | $200.0M | — | Filing → |
| GHDX | SELL | 2018-12-03 | $15.9M | — | Filing → |